SP

Surya Pratap Singh

Active Director Director DIN 10891610
DIN 10891610 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Surya Pratap Singh

Data last updated:

Surya Pratap Singh is a Director at Yashica Meditech Limited (since 2025). The company operates in Healthcare. Yashica Meditech Limited reported revenue of ₹55.8 Lakh (FY 2025).

DIN 10891610
Primary Designation Director
Industry Healthcare
First Appointment 20 Sep 2025
Largest company Yashica Meditech Limited · ₹55.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yashica Meditech Limited U72900UP2023PLC177447
Director20 Sep 2025₹55.8 Lakh (FY 2025)Active

Board colleagues of Surya Pratap Singh

Directorship timeline

Open interactive timeline →
Yashica Meditech Limited
Premium access

Shareholding and investment profile for Surya Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surya Pratap Singh

Surya Pratap Singh currently holds 1 directorship: Yashica Meditech Limited (Director, since 20 Sep 2025, revenue ₹55.8 Lakh (FY 2025)).

Surya Pratap Singh was first appointed on 20 Sep 2025 as Director at Yashica Meditech Limited.

The current boards of Surya Pratap Singh's companies include Ramesh Pratap Singh (Yashica Meditech Limited), Shiv Shanker Singh (Yashica Meditech Limited), Yashica Singh (Yashica Meditech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available